📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors. (2020)

First Author: Lochhead P

Attributed to: Discovery of ERK5 inhibitors for biomarker-driven clinical evaluation in cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.52050

Publication URI: https://www.repository.cam.ac.uk/handle/1810/304969

Type: Journal Article/Review